| Year |
Citation |
Score |
| 2022 |
Lokeshwar SD, Lopez M, Sarcan S, Aguilar K, Morera DS, Shaheen DM, Lokeshwar BL, Lokeshwar VB. Molecular Oncology of Bladder Cancer from Inception to Modern Perspective. Cancers. 14. PMID 35681556 DOI: 10.3390/cancers14112578 |
0.315 |
|
| 2021 |
Feldman AS, Lokeshwar V, Lin DW. A 25-year perspective on evaluation and understanding of biomarkers in urologic cancers. Urologic Oncology. PMID 34315659 DOI: 10.1016/j.urolonc.2021.06.010 |
0.347 |
|
| 2021 |
Kumar B, Ahmad R, Giannico GA, Zent R, Talmon GA, Harris RC, Clark PE, Lokeshwar V, Dhawan P, Singh AB. Claudin-2 inhibits renal clear cell carcinoma progression by inhibiting YAP-activation. Journal of Experimental & Clinical Cancer Research : Cr. 40: 77. PMID 33622361 DOI: 10.1186/s13046-021-01870-5 |
0.305 |
|
| 2020 |
Lokeshwar VB, Morera DS, Hasanali SL, Yates TJ, Hupe MC, Knapp J, Lokeshwar SD, Wang J, Hennig MJ, Baskar R, Escudero DO, Racine RR, Dhir N, Jordan AR, Hoye K, et al. A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Bladder Cancer Patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32094233 DOI: 10.1158/1078-0432.CCR-19-2912 |
0.399 |
|
| 2020 |
Webb E, Lokeshwar S, Sayyid R, Jordan A, Klaassen Z, Terris M, Lokeshwar V. Mp08-17 Biomarker-Targeted Novel Combination For Renal Cell Carcinoma The Journal of Urology. 203. DOI: 10.1097/Ju.0000000000000828.017 |
0.307 |
|
| 2020 |
Sayyid R, Webb E, Jordan A, Klaassen Z, Terris M, Lokeshwar V. Mp08-16 Nadc3 As A Functional Biomarker Of Renal Cell Carcinoma The Journal of Urology. 203. DOI: 10.1097/Ju.0000000000000828.016 |
0.301 |
|
| 2019 |
Kallifatidis G, Smith DK, Morera DS, Gao J, Hennig MJ, Hoy JJ, Pearce RF, Dabke IR, Li J, Merseburger AS, Kuczyk MA, Lokeshwar VB, Lokeshwar BL. β-Arrestins regulate stem cell-like phenotype and response to chemotherapy in bladder cancer. Molecular Cancer Therapeutics. PMID 30787175 DOI: 10.1158/1535-7163.MCT-18-1167 |
0.362 |
|
| 2019 |
Lokeshwar V, Rubinowicz D. Hyaluronic acid and hyaluronidase: molecular markers associated with prostate cancer biology and detection. Prostate Cancer and Prostatic Diseases. 2: S21. PMID 12496800 DOI: 10.1038/sj.pcan.4500346 |
0.33 |
|
| 2019 |
Hennig MJ, Kallifatidis G, Smith DK, Morera DS, Hupe MC, Kuczyk MA, Merseburger AS, Lokeshwar VB. Regulation of stem cell-like phenotype and response to chemotherapy in bladder cancer by beta-arrestins. Journal of Clinical Oncology. 37: 461-461. DOI: 10.1200/JCO.2019.37.7_SUPPL.461 |
0.394 |
|
| 2019 |
Lokeshwar S, Morera D, Lahorewala S, Klaassen Z, Kava B, Lokeshwar V. Mp51-01 Hyal4: First Study On A Molecular Driver And Potential Biomarker Of Invasive Bladder Cancer The Journal of Urology. 201. DOI: 10.1097/01.Ju.0000556442.76236.E8 |
0.456 |
|
| 2019 |
Hennig MJP, Kallifatidis G, Smith D, Morera D, Kuczyk M, Kramer M, Merseburger A, Lokeshwar B, Lokeshwar V. Beta-arrestins regulate stem cell-like phenotype and response to chemotherapy in bladder cancer European Urology Supplements. 18. DOI: 10.1016/S1569-9056(19)31188-1 |
0.361 |
|
| 2018 |
Kallifatidis G, Smith DK, Gao J, Pearce R, Li J, Lokeshwar V, Lokeshwar BL. Abstract 86: Beta-arrestins regulate basal cell and cancer stem cell phenotype in muscle-invasive bladder cancer Cancer Research. 78: 86-86. DOI: 10.1158/1538-7445.Am2018-86 |
0.51 |
|
| 2018 |
Hennig M, Jordan A, Kramer M, Merseburger A, Soloway M, Lokeshwar V. SLC13A3 as a functional biomarker and determinant of racial discrepancies in renal cell carcinoma European Urology Supplements. 17. DOI: 10.1016/S1569-9056(18)30937-0 |
0.305 |
|
| 2018 |
Belew D, Morera D, Lahorewala S, Jordan A, Klaassen Z, Terris M, Soloway M, Lokeshwar V. Mp58-01 Molecular Subtypes In Muscle Invasive Bladder Cancer: Evaluation Of Clinical Significance The Journal of Urology. 199. DOI: 10.1016/J.Juro.2018.02.1833 |
0.429 |
|
| 2017 |
Morera DS, Hennig MS, Talukder A, Lokeshwar SD, Wang J, Garcia-Roig M, Ortiz N, Yates TJ, Lopez LE, Kallifatidis G, Kramer MW, Jordan AR, Merseburger AS, Manoharan M, Soloway MS, ... ... Lokeshwar VB, et al. Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets. British Journal of Cancer. PMID 28972965 DOI: 10.1038/bjc.2017.318 |
0.386 |
|
| 2017 |
Hupe M, Lokeshwar S, Hennig M, Schimmelpfennig D, Kramer M, Merseburger A, Soloway M, Lokeshwar V. Mp48-01 Expression And Function Of A Novel Chondroitinase In Bladder Cancer The Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.1482 |
0.501 |
|
| 2017 |
Schimmelpfennig D, Kemper MW, Lokeshwar SD, Jordan A, Lokeshwar VB. MP44-11 BIOMARKER-DRIVEN TARGETED ORAL TREATMENT STRATEGY FOR BLADDER CANCER Journal of Urology. 197. DOI: 10.1016/j.juro.2017.02.1342 |
0.323 |
|
| 2017 |
Jordan A, Hennig M, Merseburger A, Hupe M, Kramer M, Soloway M, Lokeshwar V. Mp39-15 Sdct2 As A Functional Biomarker Of Renal Cell Carcinoma The Journal of Urology. 197. DOI: 10.1016/J.Juro.2017.02.1189 |
0.301 |
|
| 2016 |
Hennig M, Lokeshwar S, Knapp J, Hupe M, Kramer M, Manoharan M, Merseburger A, Lokeshwar V. 932 HYAL4: A novel molecular biomarker and determinant of bladder cancer European Urology Supplements. 15. DOI: 10.1016/S1569-9056(16)60934-X |
0.493 |
|
| 2016 |
Hennig M, Jordan A, Chipollini J, Hupe M, Kramer M, Lopez L, Merseburger A, Lokeshwar V. 289 Sulfated hyaluronic acid: A novel antitumor agent for bladder cancer European Urology Supplements. 15. DOI: 10.1016/S1569-9056(16)60291-9 |
0.489 |
|
| 2016 |
Hennig MJ, Lokeshwar SD, Wilson SN, Knapp J, Hupe MC, Jordan AR, Manoharan M, Kramer MW, Merseburger AS, Lopez LE, Lokeshwar VB. MP88-18 HYAL4: A MOLECULAR MARKER AND DETERMINANT OF BLADDER CANCER PROGRESSION Journal of Urology. 195. DOI: 10.1016/J.JURO.2016.02.2436 |
0.402 |
|
| 2015 |
Schmitz-Dräger BJ, Droller M, Lokeshwar VB, Lotan Y, Hudson MA, van Rhijn BW, Marberger MJ, Fradet Y, Hemstreet GP, Malmstrom PU, Ogawa O, Karakiewicz PI, Shariat SF. Molecular markers for bladder cancer screening, early diagnosis, and surveillance: the WHO/ICUD consensus. Urologia Internationalis. 94: 1-24. PMID 25501325 DOI: 10.1159/000369357 |
0.332 |
|
| 2015 |
Jordan AR, Chipollini J, Lopez L, Yates T, Lokeshwar V. Abstract 2647: Anti-tumor activity of sHA8k, a HYAL1 hyaluronidase inhibitor, in bladder cancer cells Cancer Research. 75: 2647-2647. DOI: 10.1158/1538-7445.Am2015-2647 |
0.423 |
|
| 2015 |
Chipollini J, Racine R, Lopez L, Lokeshwar S, Yates T, Lokeshwar V. Mp45-03 Targeting Of Biomarkers Of Bladder Cancer Metastasis By 4-Methylumbelliferone The Journal of Urology. 193. DOI: 10.1016/J.Juro.2015.02.1501 |
0.47 |
|
| 2014 |
Chen LM, Chang M, Dai Y, Chai KX, Dyrskjøt L, Sanchez-Carbayo M, Szarvas T, Zwarthoff EC, Lokeshwar V, Jeronimo C, Parker AS, Ross S, Borre M, Orntoft TF, Jaeger T, et al. External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohort. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1804-12. PMID 24920641 DOI: 10.1158/1055-9965.Epi-14-0029 |
0.323 |
|
| 2014 |
Gosalbez M, Hupe MC, Lokeshwar SD, Yates TJ, Shields J, Veerapen MK, Merseburger AS, Rosser CJ, Soloway MS, Lokeshwar VB. Differential expression of SDF-1 isoforms in bladder cancer. The Journal of Urology. 191: 1899-905. PMID 24291546 DOI: 10.1016/j.juro.2013.11.053 |
0.304 |
|
| 2014 |
Alonzo D, Yates T, Hoye K, Lokeshwar V. MP21-14 UTILIZING DIETARY SUPPLEMENTS TO TARGET BIOMARKERS OF BLADDER CANCER METASTASIS Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.842 |
0.477 |
|
| 2014 |
Ortiz N, Garcia-Roig M, Yates T, Manoharan M, Lokeshwar V. Mp29-14 Targeting Hyaluronic Acid Family Biomarkers For Treatment Of Renal Cell Carcinoma The Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.756 |
0.349 |
|
| 2014 |
Shields J, Gosalbez M, Hupe M, Lokeshwar S, Yates T, Soloway M, Lokeshwar V. Mp28-17 Differential Expression Of Stroma Derived Factor-1 Isoforms In Bladder Cancer The Journal of Urology. 191: 1899. DOI: 10.1016/J.Juro.2014.02.666 |
0.415 |
|
| 2014 |
Shields J, Lokeshwar S, Hoye K, Yates T, Manoharan M, Lokeshwar V. Mp28-15 Hyal4: A New Hyaluronidase Associated With Bladder Cancer Diagnosis And Prognosis The Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.664 |
0.477 |
|
| 2014 |
Alonzo D, Yates T, Lopez L, Hupe M, Lokeshwar V. MP24-18 4-METHYLUMBELLIFERONE: DIETARY SUPPLEMENT TURNED CHEMO-PREVENTIVE AND ANTI-METASTATIC AGENT FOR PROSTATE CANCER Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.299 |
0.382 |
|
| 2013 |
Yates T, Alonzo D, Lokeshwar S, Hoye K, Lopez LE, Hupe M, Lokeshwar V. Abstract 2681: 4-methylumbelliferone: Dietary supplement turned chemo-preventive and anti-metastatic agent for prostate cancer Cancer Research. 74: 2681-2681. DOI: 10.1158/1538-7445.Am2014-2681 |
0.4 |
|
| 2013 |
Ortiz N, Yates T, Lopez L, Hupe M, Lokeshwar V. 495 Chemoprevention Of Tumor Progression And Metastasis In Prostate Cancer By Nutraceutical, 4-Methylumbelliferone The Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.1889 |
0.423 |
|
| 2013 |
Garcia-Roig M, Ortiz N, Yates T, Soloway M, Bird V, Lokeshwar V. 606 Prognostic Significance Of Hyaluronic Acid Family For Metastatic Renal Cell Carcinoma The Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.157 |
0.354 |
|
| 2012 |
Chi A, Shirodkar SP, Escudero DO, Ekwenna OO, Yates TJ, Ayyathurai R, Garcia-Roig M, Gahan JC, Manoharan M, Bird VG, Lokeshwar VB. Molecular characterization of kidney cancer: association of hyaluronic acid family with histological subtypes and metastasis. Cancer. 118: 2394-402. PMID 21887686 DOI: 10.1002/cncr.26520 |
0.338 |
|
| 2012 |
Yates T, Garcia-Roig M, Veerapen MK, Benitez A, Lokeshwar V. Abstract 336: 4-methylumbeliferone, an HA synthesis inhibitor, inhibits EMT determinants in bladder cancer cell lines Cancer Research. 72: 336-336. DOI: 10.1158/1538-7445.Am2012-336 |
0.503 |
|
| 2011 |
Benitez A, Yates TJ, Lopez LE, Cerwinka WH, Bakkar A, Lokeshwar VB. Targeting hyaluronidase for cancer therapy: antitumor activity of sulfated hyaluronic acid in prostate cancer cells. Cancer Research. 71: 4085-95. PMID 21555367 DOI: 10.1158/0008-5472.CAN-10-4610 |
0.362 |
|
| 2011 |
Kramer MW, Escudero DO, Lokeshwar SD, Golshani R, Ekwenna OO, Acosta K, Merseburger AS, Soloway M, Lokeshwar VB. Association of hyaluronic acid family members (HAS1, HAS2, and HYAL-1) with bladder cancer diagnosis and prognosis. Cancer. 117: 1197-209. PMID 20960509 DOI: 10.1002/Cncr.25565 |
0.762 |
|
| 2011 |
Benitez A, Yates T, Chi A, Gahan J, Bird V, Lokeshwar V. Abstract 2598: RHAMM- A potential predictor of metastasis and therapeutic target in kidney cancer Cancer Research. 71: 2598-2598. DOI: 10.1158/1538-7445.Am2011-2598 |
0.458 |
|
| 2011 |
Ekwenna O, Yates T, Gosalbez M, Lokeshwar S, Shirodkar S, Manoharan M, Soloway M, Lokeshwar V. 1354 Chemokine Sdf1-B And Receptor Cxcr7: Functionally Associated Molecular Markers For Bladder Cancer Diagnosis And Prognosis The Journal of Urology. 189. DOI: 10.1016/J.Juro.2013.02.503 |
0.417 |
|
| 2011 |
Young EE, Yates T, Benitez A, Lopez LE, Lokeshwar VB. 1281 ANTI-TUMOR ACTIVITY OF SULFATED HYALURONIC ACID, A HYAL1 HYALURONIDASE INHIBITOR, IN PROSTATE CANCER CELLS Journal of Urology. 185. DOI: 10.1016/J.JURO.2011.02.967 |
0.314 |
|
| 2011 |
Gahan J, Benitez A, Yates T, Chi A, Bird V, Lokeshwar V. 386 Targeting Rhamm, A Metastasis Predictor, For Kidney Cancer Therapy The Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.474 |
0.414 |
|
| 2010 |
Kramer MW, Golshani R, Merseburger AS, Knapp J, Garcia A, Hennenlotter J, Duncan RC, Soloway MS, Jorda M, Kuczyk MA, Stenzl A, Lokeshwar VB. HYAL-1 hyaluronidase: a potential prognostic indicator for progression to muscle invasion and recurrence in bladder cancer. European Urology. 57: 86-93. PMID 19345473 DOI: 10.1016/J.Eururo.2009.03.057 |
0.769 |
|
| 2010 |
Shirodkar S, Chi A, Lopez L, Munoz D, Escuerdo D, Lokeshwar V. 238 Anti-Tumor Activity Of 4-Methylumbelliferone, A Hyaluronic Acid Synthesis Inhibitor, In Prostate Cancer Cells The Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.296 |
0.415 |
|
| 2010 |
Kramer MW, Escudero D, Golshani R, Lokeshwar S, Merseburger AS, Kuczyk MA, Soloway MS, Lokeshwar VB. 963 DIAGNOSIS, METASTASIS AND RECURRENCE OF TRANSITIONAL CELL CARCINOMA OF THE BLADDER ARE ASSOCIATED WITH EXPRESSION OF HYALURONIC ACID REGULATORS Journal of Urology. 183. DOI: 10.1016/J.JURO.2010.02.1910 |
0.732 |
|
| 2010 |
Chi A, Shirodkar S, Gosalbez M, Bird V, Aziz M, Sheilds J, Soloway M, Lokeshwar V. 71 Molecular Targets In Kidney Cancer The Journal of Urology. 183. DOI: 10.1016/J.Juro.2010.02.119 |
0.412 |
|
| 2009 |
Shirodkar SP, Lokeshwar VB. Potential new urinary markers in the early detection of bladder cancer. Current Opinion in Urology. 19: 488-93. PMID 19584734 DOI: 10.1097/MOU.0b013e32832eb3a0 |
0.381 |
|
| 2009 |
Hautmann S, Lokeshwar VB, Juenemann KP. [Urine-based diagnostics: an update on the Kiel Tumor Bank]. Der Urologe. Ausg. A. 48: 619-24. PMID 19557467 DOI: 10.1007/s00120-009-1991-7 |
0.397 |
|
| 2009 |
Knapp J, Lokeshwar S, Gosalbez M, Yu H, Kramer M, Merseburger A, Stenzl A, Soloway MS, Lokeshwar V. HYAL4: A NEW PLAYER IN BLADDER CANCER PROGRESSION AND DIAGNOSIS Journal of Urology. 181: 417-417. DOI: 10.1016/S0022-5347(09)61183-6 |
0.473 |
|
| 2009 |
Gosalbez M, Knapp J, Gomez C, Lokeshwar S, Kramer M, Besharat K, Stenzl A, Soloiway MS, Lokeshwar B, Lokeshwar V. Chemokine Receptor Cxcr7 Is A Molecular Determinant Of Bladder Cancer The Journal of Urology. 181: 303-303. DOI: 10.1016/S0022-5347(09)60864-8 |
0.431 |
|
| 2008 |
Caruso DJ, Carmack AJ, Lokeshwar VB, Duncan RC, Soloway MS, Lokeshwar BL. Osteopontin and interleukin-8 expression is independently associated with prostate cancer recurrence. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 4111-8. PMID 18593988 DOI: 10.1016/S0022-5347(08)62098-4 |
0.388 |
|
| 2008 |
Lokeshwar VB, Selzer MG. Hyalurondiase: both a tumor promoter and suppressor. Seminars in Cancer Biology. 18: 281-7. PMID 18448355 DOI: 10.1016/j.semcancer.2008.03.008 |
0.309 |
|
| 2008 |
Golshani R, Lopez L, Estrella V, Kramer M, Iida N, Lokeshwar VB. Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44. Cancer Research. 68: 483-91. PMID 18199543 DOI: 10.1158/0008-5472.Can-07-2140 |
0.742 |
|
| 2008 |
Gomez P, Kramer MW, Lopez L, Manoharan M, Soloway MS, Lokeshwar V. Regulation Of Bladder Tumor Marker, Hyal1 Hyaluronidase: Implications In Diagnosis And Therapy The Journal of Urology. 179: 262-262. DOI: 10.1016/S0022-5347(08)60760-0 |
0.335 |
|
| 2008 |
Kramer M, Golshani R, Caruso DJ, Manoharon M, Soloway MS, Lokeshwar V. A Urine-Based Real Time Rt-Pcr Assay For Hyal1 Hyaluronidase And Ha-Synthase To Detect Bladder Cancer The Journal of Urology. 179: 68-69. DOI: 10.1016/S0022-5347(08)60201-3 |
0.747 |
|
| 2007 |
Alvarez A, Lokeshwar VB. Bladder cancer biomarkers: current developments and future implementation. Current Opinion in Urology. 17: 341-6. PMID 17762628 DOI: 10.1097/MOU.0b013e3282c8c72b |
0.387 |
|
| 2007 |
Golshani R, Hautmann SH, Estrella V, Cohen BL, Kyle CC, Manoharan M, Jorda M, Soloway MS, Lokeshwar VB. HAS1 expression in bladder cancer and its relation to urinary HA test. International Journal of Cancer. Journal International Du Cancer. 120: 1712-20. PMID 17230515 DOI: 10.1002/Ijc.22222 |
0.771 |
|
| 2007 |
Kramer M, Golshani R, Merseburger A, Hennenlotter J, Soloway M, Kuczyk M, Lokeshwar V. 383 HYALURONIC ACID AND HYAL1 HYALURONIDASE: PROGNOSTIC MARKERS FOR BLADDER CANCER European Urology Supplements. 6: 118. DOI: 10.1016/S1569-9056(07)60382-0 |
0.775 |
|
| 2007 |
Kramer MW, Golshani R, Merseburger AS, Garcia A, Hennenlotter J, Soloway MS, Kuczyk MA, Lokeshwar VB. 890: Hyaluronic Acid and HYAL1 Hyaluronidase: Predictors of Bladder Cancer Prognosis The Journal of Urology. 177: 296-296. DOI: 10.1016/S0022-5347(18)31118-2 |
0.773 |
|
| 2006 |
Lokeshwar VB, Estrella V, Lopez L, Kramer M, Gomez P, Soloway MS, Lokeshwar BL. HYAL1-v1, an alternatively spliced variant of HYAL1 hyaluronidase: a negative regulator of bladder cancer. Cancer Research. 66: 11219-27. PMID 17145867 DOI: 10.1158/0008-5472.CAN-06-1121 |
0.304 |
|
| 2006 |
Lokeshwar VB, Selzer MG. Urinary bladder tumor markers. Urologic Oncology. 24: 528-37. PMID 17138134 DOI: 10.1016/j.urolonc.2006.07.003 |
0.355 |
|
| 2006 |
Lokeshwar VB. Are there molecular signatures for predicting bladder cancer prognosis? The Journal of Urology. 176: 2347-8. PMID 17085098 DOI: 10.1016/j.juro.2006.08.142 |
0.357 |
|
| 2006 |
Lokeshwar VB, Selzer MG, Unwala DJ, Estrella V, Gomez MF, Golshani R, Kester RR, Klumpp DJ, Gousse AE. Uronate peaks and urinary hyaluronic acid levels correlate with interstitial cystitis severity. The Journal of Urology. 176: 1001-7. PMID 16890679 DOI: 10.1016/J.Juro.2006.04.012 |
0.703 |
|
| 2006 |
Cohen BL, Gomez P, Omori Y, Duncan RC, Civantos F, Soloway MS, Lokeshwar VB, Lokeshwar BL. Cyclooxygenase-2 (COX-2) expression is an independent predictor of prostate cancer recurrence. International Journal of Cancer. Journal International Du Cancer. 119: 1082-7. PMID 16557596 DOI: 10.1002/ijc.21749 |
0.306 |
|
| 2006 |
Golshani R, Hautmann SH, Cohen BL, Manoharan M, Soloway MS, Lokeshwar VB. 985: HAS1 Expression in Bladder Cancer and its Real Tion to Urinary HA Test The Journal of Urology. 175: 317-318. DOI: 10.1016/S0022-5347(18)33210-5 |
0.77 |
|
| 2005 |
Habuchi T, Marberger M, Droller MJ, Hemstreet GP, Grossman HB, Schalken JA, Schmitz-Dräger BJ, Murphy WM, Bono AV, Goebell P, Getzenberg RH, Hautmann SH, Messing E, Fradet Y, Lokeshwar VB. Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers. Urology. 66: 64-74. PMID 16399416 DOI: 10.1016/J.Urology.2005.08.065 |
0.393 |
|
| 2005 |
Lokeshwar VB, Habuchi T, Grossman HB, Murphy WM, Hautmann SH, Hemstreet GP, Bono AV, Getzenberg RH, Goebell P, Schmitz-Dräger BJ, Schalken JA, Fradet Y, Marberger M, Messing E, Droller MJ. Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers. Urology. 66: 35-63. PMID 16399415 DOI: 10.1016/J.Urology.2005.08.064 |
0.377 |
|
| 2005 |
Lokeshwar VB, Cerwinka WH, Isoyama T, Lokeshwar BL. HYAL1 hyaluronidase in prostate cancer: a tumor promoter and suppressor. Cancer Research. 65: 7782-9. PMID 16140946 DOI: 10.1158/0008-5472.CAN-05-1022 |
0.354 |
|
| 2005 |
Lokeshwar VB, Cerwinka WH, Lokeshwar BL. HYAL1 hyaluronidase: a molecular determinant of bladder tumor growth and invasion. Cancer Research. 65: 2243-50. PMID 15781637 DOI: 10.1158/0008-5472.CAN-04-2805 |
0.33 |
|
| 2005 |
Hautmann S, Braun P, Juenemann K, Gomez ML, Schroeder G, Friedrich M, Toma M, Huland H, Lokeshwar V. 631A comparative study of cytology and biomarkers: HA-HAASE, hemastix detection, BTA-STAT and UBC-rapid for bladder cancer detection in urine European Urology Supplements. 4: 160. DOI: 10.1016/S1569-9056(05)80635-9 |
0.43 |
|
| 2004 |
Hautmann S, Toma M, Lorenzo Gomez MF, Friedrich MG, Jaekel T, Michl U, Schroeder GL, Huland H, Juenemann KP, Lokeshwar VB. Immunocyt and the HA-HAase urine tests for the detection of bladder cancer: a side-by-side comparison. European Urology. 46: 466-71. PMID 15363562 DOI: 10.1016/j.eururo.2004.06.006 |
0.359 |
|
| 2004 |
Schroeder GL, Lorenzo-Gomez MF, Hautmann SH, Friedrich MG, Ekici S, Huland H, Lokeshwar V. A side by side comparison of cytology and biomarkers for bladder cancer detection. The Journal of Urology. 172: 1123-6. PMID 15311054 DOI: 10.1097/01.Ju.0000134347.14643.Ab |
0.502 |
|
| 2004 |
Ekici S, Cerwinka WH, Duncan R, Gomez P, Civantos F, Soloway MS, Lokeshwar VB. Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer. International Journal of Cancer. 112: 121-9. PMID 15305383 DOI: 10.1002/ijc.20368 |
0.332 |
|
| 2003 |
Simon MA, Lokeshwar VB, Soloway MS. Current bladder cancer tests: unnecessary or beneficial? Critical Reviews in Oncology/Hematology. 47: 91-107. PMID 12900004 DOI: 10.1016/S1040-8428(03)00074-X |
0.426 |
|
| 2003 |
Franzmann EJ, Schroeder GL, Goodwin WJ, Weed DT, Fisher P, Lokeshwar VB. Expression of tumor markers hyaluronic acid and hyaluronidase (HYAL1) in head and neck tumors. International Journal of Cancer. 106: 438-45. PMID 12845686 DOI: 10.1002/ijc.11252 |
0.324 |
|
| 2003 |
Posey JT, Soloway MS, Ekici S, Sofer M, Civantos F, Duncan RC, Lokeshwar VB. Evaluation of the prognostic potential of hyaluronic acid and hyaluronidase (HYAL1) for prostate cancer Cancer Research. 63: 2638-2644. PMID 12750291 |
0.336 |
|
| 2003 |
Lorenzo-Gomez M, Schroeder G, Hautmann S, Friedrich M, Ekici S, Huland H, Lokeshwar V. Side-by-side comparison of bladder cancer tests in a multi-center study European Urology Supplements. 2: 111. DOI: 10.1016/S1569-9056(03)80439-6 |
0.354 |
|
| 2002 |
Lokeshwar VB, Schroeder GL, Carey RI, Soloway MS, Iida N. Regulation of hyaluronidase activity by alternative mRNA splicing. The Journal of Biological Chemistry. 277: 33654-63. PMID 12084718 DOI: 10.1074/jbc.M203821200 |
0.339 |
|
| 2001 |
Lokeshwar V, Schroeder G, Hautmann S, Selzer M. Hyaluronic Acid and Hyaluronidase: Accurate Tumor Markers and Tumor Progression Regulators. Thescientificworldjournal. 1: 106. PMID 30147586 DOI: 10.1100/Tsw.2001.120 |
0.512 |
|
| 2001 |
Hautmann SH, Schroeder GL, Civantos F, Duncan RC, Gnann R, Friedrich MG, Hellstern A, Huland H, Soloway MS, Lokeshwar VB. [Hyaluronic acid and hyaluronidase. 2 new bladder carcinoma markers]. Der Urologe. Ausg. A. 40: 121-6. PMID 11315586 DOI: 10.1007/s001200050449 |
0.506 |
|
| 2001 |
Lokeshwar VB, Rubinowicz D, Schroeder GL, Forgacs E, Minna JD, Block NL, Nadji M, Lokeshwar BL. Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer. The Journal of Biological Chemistry. 276: 11922-32. PMID 11278412 DOI: 10.1074/jbc.M008432200 |
0.351 |
|
| 2001 |
HAUTMANN SH, LOKESHWAR VB, SCHROEDER GL, CIVANTOS F, DUNCAN RC, GNANN R, FRIEDRICH MG, SOLOWAY MS. ELEVATED TISSUE EXPRESSION OF HYALURONIC ACID AND HYALURONIDASE VALIDATES THE HA-HAase URINE TEST FOR BLADDER CANCER Journal of Urology. 165: 2068-2074. DOI: 10.1016/S0022-5347(05)66296-9 |
0.452 |
|
| 2000 |
Lokeshwar VB, Block NL. HA-HAase urine test. A sensitive and specific method for detecting bladder cancer and evaluating its grade. The Urologic Clinics of North America. 27: 53-61. PMID 10696245 DOI: 10.1016/S0094-0143(05)70234-2 |
0.433 |
|
| 2000 |
Lokeshwar VB, Obek C, Pham HT, Wei D, Young MJ, Duncan RC, Soloway MS, Block NL. Urinary hyaluronic acid and hyaluronidase: markers for bladder cancer detection and evaluation of grade. The Journal of Urology. 163: 348-56. PMID 10604388 DOI: 10.1016/S0022-5347(05)68050-0 |
0.504 |
|
| 1999 |
Young M, Iida N, Lokeshwar V. Expression Of Bladder Tumor (Bt) Marker, Hyaluronic Acid In Bt Cells: Reversal Of Dogma? The Journal of Urology. 149. DOI: 10.1097/00005392-199904010-00600 |
0.436 |
|
| 1999 |
Lokeshwar V, Selzer M, Goudarzi G, Young M, Block N. The First Tumor-Derived Hyaluronidase: A High Grade Bladder Tumor Marker The Journal of Urology. 149. DOI: 10.1097/00005392-199904010-00598 |
0.322 |
|
| 1998 |
Lokeshwar VB, Soloway MS, Block NL. Secretion of bladder tumor-derived hyaluronidase activity by invasive bladder tumor cells. Cancer Letters. 131: 21-7. PMID 9839616 DOI: 10.1016/S0304-3835(98)00197-9 |
0.333 |
|
| Show low-probability matches. |